137 related articles for article (PubMed ID: 21352279)
1. Clinical implications of leukocytapheresis using a centrifugal cell separator for steroid-resistant pyoderma gangrenosum associated with inflammatory bowel disease.
Hanafusa T; Azukizawa H; Umegaki N; Tani M; Yamaguchi Y; Katayama I
J Dermatol; 2011 May; 38(5):507-10. PubMed ID: 21352279
[No Abstract] [Full Text] [Related]
2. Pyoderma gangraenosum.
Wollina U; Haroske G
Curr Opin Rheumatol; 2011 Jan; 23(1):50-6. PubMed ID: 21037478
[TBL] [Abstract][Full Text] [Related]
3. A case report of steroid and immunosuppressant-resistant pyoderma gangrenosum successfully treated by granulocytapheresis.
Okuma K; Mitsuishi K; Hasegawa T; Tsuchihashi H; Ogawa H; Ikeda S
Ther Apher Dial; 2007 Oct; 11(5):387-90. PubMed ID: 17845399
[TBL] [Abstract][Full Text] [Related]
4. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
Regueiro M; Valentine J; Plevy S; Fleisher MR; Lichtenstein GR
Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338
[TBL] [Abstract][Full Text] [Related]
5. Leukocytapheresis treatment for pyoderma gangrenosum.
Fujimoto E; Fujimoto N; Kuroda K; Tajima S
Br J Dermatol; 2004 Nov; 151(5):1090-2. PubMed ID: 15541092
[TBL] [Abstract][Full Text] [Related]
6. [Infliximab for the management of pyoderma gangrenosum in inflammatory bowel disease: one for all?].
Tanczos BT; Baumgart DC
Z Gastroenterol; 2006 Jul; 44(7):609-10. PubMed ID: 16823703
[No Abstract] [Full Text] [Related]
7. [Pyoderma gangrenosum: case series].
Richetta AG; Maiani E; Carboni V; Carlomagno V; Cimillo M; Mattozzi C; Calvieri S
Clin Ter; 2007; 158(4):325-9. PubMed ID: 17953284
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment with infliximab for refractory pyoderma gangrenosum associated with inflammatory bowel disease.
Hayashi H; Kuwabara C; Tarumi K; Makino E; Fujimoto W
J Dermatol; 2012 Jun; 39(6):576-8. PubMed ID: 21958000
[No Abstract] [Full Text] [Related]
9. Pyoderma Gangrenosum: A Review for the Gastroenterologist.
Plumptre I; Knabel D; Tomecki K
Inflamm Bowel Dis; 2018 Nov; 24(12):2510-2517. PubMed ID: 29788368
[TBL] [Abstract][Full Text] [Related]
10. [Pyoderma gangrenosum--a less well known ulcerous skin disease].
Kostiainen M; Snellman E; Vaalasti A; Rantanen T; Reunala T
Duodecim; 2002; 118(10):1033-7. PubMed ID: 12237998
[No Abstract] [Full Text] [Related]
11. Pyoderma gangrenosum.
Besur SV; Tadakamalla A; Talluri SK
QJM; 2012 Dec; 105(12):1219-20. PubMed ID: 22006562
[No Abstract] [Full Text] [Related]
12. [Pregnancy: a possible etiology of pyoderma gangrenosum. A case report and review of the literature].
Sergent F; Joly P; Gravier A; Verspyck E; Marpeau L
J Gynecol Obstet Biol Reprod (Paris); 2002 Sep; 31(5):506-11. PubMed ID: 12379836
[TBL] [Abstract][Full Text] [Related]
13. Important cutaneous manifestations of inflammatory bowel disease.
Trost LB; McDonnell JK
Postgrad Med J; 2005 Sep; 81(959):580-5. PubMed ID: 16143688
[TBL] [Abstract][Full Text] [Related]
14. Case study: diagnosis and treatment of pyoderma gangrenosum.
Burton J
Br J Nurs; 2005 Sep 8-21; 14(16):S10-3. PubMed ID: 16215496
[TBL] [Abstract][Full Text] [Related]
15. Neutrophilic dermatoses: a review of current treatment options.
Cohen PR
Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
[TBL] [Abstract][Full Text] [Related]
16. Management of peristomal pyoderma gangrenosum.
Kiran RP; O'Brien-Ermlich B; Achkar JP; Fazio VW; Delaney CP
Dis Colon Rectum; 2005 Jul; 48(7):1397-403. PubMed ID: 15868233
[TBL] [Abstract][Full Text] [Related]
17. Pyoderma gangrenosum following cesarean delivery.
Steadman UA; Brennan TE; Daman LA; Curry SL
Obstet Gynecol; 1998 May; 91(5 Pt 2):834-6. PubMed ID: 9572181
[TBL] [Abstract][Full Text] [Related]
18. Use of infliximab in pyoderma gangrenosum.
Hewitt D; Tait C
Australas J Dermatol; 2007 May; 48(2):95-8. PubMed ID: 17535196
[TBL] [Abstract][Full Text] [Related]
19. Pustular pyoderma gangrenosum.
Shankar S; Sterling JC; Rytina E
Clin Exp Dermatol; 2003 Nov; 28(6):600-3. PubMed ID: 14616824
[TBL] [Abstract][Full Text] [Related]
20. Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease.
Friedman S; Marion JF; Scherl E; Rubin PH; Present DH
Inflamm Bowel Dis; 2001 Feb; 7(1):1-7. PubMed ID: 11233655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
